Cargando…
RNA interference as a therapeutic strategy for treating CNS disorders
RNA interference (RNAi) controls gene silencing in most living organisms. The potential clinical applications of RNAi represent a strategy with unsurpassed selectivity, with the ability to target multiple disease-related genes, independent of their perceived drugability. The design of highly selecti...
Autores principales: | Hoyer, Daniel, Dev, Kumlesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105917/ https://www.ncbi.nlm.nih.gov/pubmed/32288775 http://dx.doi.org/10.1016/j.ddstr.2006.10.008 |
Ejemplares similares
-
The Effects of Antipsychotics in Experimental Models of Krabbe Disease
por: Sharma, Kapil, et al.
Publicado: (2023) -
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations
por: Sheridan, Graham K., et al.
Publicado: (2014) -
The therapeutic potential of RNA interference
por: Uprichard, Susan L.
Publicado: (2005) -
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders
por: Kubo, Takekazu, et al.
Publicado: (2008) -
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
por: Guo, Zi-Hua, et al.
Publicado: (2023)